Text of TX SCR 3 (2023)
Expressing support for ending "gender-affirming care."
Legislative text is a public record. Where LegiScan supplied it, the CC BY 4.0 credit applies.
Source: LegiScan. Bill data and text from LegiScan (legiscan.com), licensed CC BY 4.0 and used in modified form. LegiScan does not endorse the Trans Data Initiative. License: CC BY 4.0(opens another site). Source page(opens another site)
As introduced
3,252 characters
88R3473 BPG-D
By: Hall, Campbell
S.C.R. No. 3
CONCURRENT RESOLUTION
WHEREAS, The American Academy of Pediatrics, American
Medical Association, and Children's Hospital Association wrote a
letter to the United States Attorney General on October 3, 2022,
requesting a Department of Justice investigation of organizations,
individuals, and entities that advocate against what they term
"gender-affirming health care"; and
WHEREAS, "Gender-affirming care" is an unconscionable
misnomer for the abhorrent practice of genital mutilation and the
administration of puberty blockers to children who can not even
legally smoke cigarettes; such "care" leads to irreparable harm,
psychological damage, and a lifetime of trauma; and
WHEREAS, The defenders of "gender-affirming" treatment wish
to silence the voices of those who have undergone gender
transitions and are left with immense, debilitating regret; they
ignore that other countries have examined the issue of whether
minors can adequately understand and properly consent to
"gender-affirming care"; in a landmark 2020 High Court decision in
the United Kingdom, the court ruled that the capacity to legally
consent to taking puberty blockers was "highly unlikely" for
13-year-olds and "doubtful" for 14- and 15-year-olds;
consequently, the use of puberty blockers was suspended for
children under the age of 16; and
WHEREAS, In July 2022, the U.S. Food and Drug Administration
issued a warning regarding gonadotropin-releasing hormone
agonists, commonly known as puberty blockers; the FDA identified a
plausible association between GnRH agonist use and pseudotumor
cerebri, also known as idiopathic intracranial hypertension, which
occurs when pressure inside the skull spontaneously increases; the
condition can cause brain swelling, severe headaches, nausea,
double vision, and even permanent vision loss, according to the
Mayo Clinic; and
WHEREAS, "Gender-affirming care" is a dangerous practice
that destroys lives, and those who would suppress opposition to
such treatment are deserving of the harshest censure; now,
therefore, be it
RESOLVED, That the 88th Legislature of the State of Texas
hereby express support for ending "gender-affirming care" and
condemn the American Academy of Pediatrics, American Medical
Association, and Children's Hospital Association for their attempt
to suppress objections to such treatment.